Remark Med (MARK) Reports Q2 Loss of $0.34/Share
Remark Med (NASD
AQ: MARK) reported Q2 EPS of ($0.34), versus ($0.19) reported last year.
For earnings history and earnings-related data on Remark Med (MARK) click here.
AQ: MARK) reported Q2 EPS of ($0.34), versus ($0.19) reported last year.For earnings history and earnings-related data on Remark Med (MARK) click here.